This study assessed the presentation, treatment, and prognosis of primary gastric lymphoma in general hospital practice and its relation to infection with Helicobacter pyloni.
Primary gastric lymphoma accounts for between 1-5% of all gastric malignancies.1 Even when confounding factors such as the decreased incidence of gastric carcinoma are taken into account the incidence of primary gastric lymphoma seems to be increasing.2A Survival has been shown to depend on the histological grade at presentation.5 8 Patients with low grade disease with low depth of infiltration and radical resectability of the gastric lymphoma have been shown to have the best prognosis.7 8 In a prospective study RuskoneFoumestraux et al 9 showed that the combination of surgery and chemotherapy in patients with high grade disease was associated with an improved survival compared with patients treated with chemotherapy alone.
Recent interest in the relation between Helicobacter pylori and gastric carcinoma10 has prompted an analysis of the presence of this organism in patients with gastric lymphoma. Wotherspoon et al l l found a 92% incidence of Hpylori in 1 10 patients with gastric lymphoma, an order similar to that found in patients with gastric carcinoma but much higher than in the general population. Many primary gastric lymphomas are now recognised to be B cell lymphomas of mucosa associated lymphoid tissue (MALT). While MALT is not normally found in the gastric mucosa, it may develop after chronic inflammation such as is seen with H pylori infection. It has been proposed that MALT, acquired in response to infection provides a background for the development of both gastric carcinoma and lymphoma.1 [1] [2] [3] [4] [5] In five of six patients with low grade primary gastric lymphoma, Hpylori eradication therapy has been shown to lead to a regression of the lymphoma. 13 Clinical experience in routine general hospital practice suggests that very few cases of primary gastric lymphoma, even in patients with low grade disease, present at such an early stage as those seen in a tertiary referral centre.13 This study aimed to assess whether there were two patterns of presentation for primary gastric lymphoma, the 'gastritis' type described by Wotherspoon et al 13 and the 'tumour' type. We also assessed the presentation and importance of the stage and grade of these tumours at diagnosis, the bulk of the lesions, the prognosis, how the patients were treated (by radiotherapy or chemotherapy with or without surgery), and the proportion in which H pylori was seen. 
Methods

Results
Fifty one patients were identified from the lymphoma registry and pathology records. Two patients were excluded from further analysis because of a revised diagnosis of carcinoma in one and disseminated non-Hodgkin's lymphoma with infiltration of stomach. Four other cases were excluded because no material was available for histopathological assessment in three and insufficient material to make a diagnosis in one leaving 45 patients for analysis. The mean (SD) age of the group was 65 (11) years and the range 25-84. The male: female ratio was 1:5:1.
Presenting symptoms (Table) These were similar to gastric cancer. The predominant symptom was that of epigastric pain.
Histopathology
All of the tumours were of B cell origin. There was a non-significant trend for 90 improved survival in both patients with stage I disease (p<0 1, Fig 3) and those who had 80 received surgery as part of their treatment 70 compared with those treated medically (Fig 4) . There werefive deathsfrom othercauses. stomach may have been greater than could be appreciated from the endoscopic biopsies and computed tomography, but endoscopic ultrathree postoperative deaths. Of the remaining sound, which may be of benefit in assessing 16 patients all except one were electively given depth of invasion, was not available. postoperative chemotherapy (n= 10) or radioIt is possible that early MALT tumours are therapy (n= 5).
being missed because of their non-specific Twenty one patients did not undergo surgery 'gastritis' type appearance at endoscopy. We but were treated with either chemotherapy or believe, however, that it is unlikely that we radiotherapy (or a combination of the two). The have missed significant progressive disease as chemotherapy treatment in these patients was none of the patients had a previous histological tailored to the histological grade of the tumour diagnosis of 'gastritis'. None the less, for and the age of the patient. Six patients with low patients with unexplained symptoms in the grade disease were treated with chlorambucil presence of gastritis, biopsy specimens should alone. Patients in whom there was concern be taken. We do not know if some patients preabout the cardiotoxicity of adriamycin (typically senting in the earlier part of this study, when the frail and the elderly) were treated with immunocytochemistry was not available, may the MCOP regimen (mitozantrone, cyclophos-have been misclassified as carcinoma. phamide, vincristine, and prednisolone). 23 Hussell et al 12 have shown that the proliferaThirteen patients were treated with CHOP tion of low grade B cell primary gastric (cyclophosphamide, adriamycin, vincristine, lymphoma is dependent upon specific activaand prednisolone) or a CHOP variant.24 One tion of T cells by H pylori together with the patient was treated with a combination of release of cytokines that drive B cell activation ifosfamide and mitozantrone. 25 and proliferation. In five of six cases of Two patients died from second tumours low grade primary gastric lymphoma, (carcinomas) different from their original lym-Wotherspoon et al'3 saw regression of the phoma.
lymphoma after successful eradication of The overall five year survival for the group H pylori. These findings prompted the recomirrespective of stage, grade of tumour or treat-mendation that patients with low grade disease ment was 40% (Fig 1) . Figure 2 shows that should receive Hpylori eradication therapy as a there was no difference in cause specific sur-first line treatment with prolonged follow vival between low and high grade lymphomas. up rather than the conventional surgery, chemotherapy or radiotherapy. ' The authors acknowledge the help of Mrs J Thomley for retrieval of case notes and data and to the British National Lymphoma Investigation for their help with many of these cases at the time of presentation.
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